Nanoplastics Worsen Asthma Through Neuropeptide-Driven Gut-Lung Immune Feedback Loop | Research

The takeaway

Nanoplastic particles worsen asthma by triggering the release of neuropeptides substance P and CGRP, creating a self-reinforcing inflammatory loop connecting the gut and lungs.

PLA2-TRPV1-neuropeptide feedback loop
Nanoplastics activate a self-reinforcing cycle where lung PLA2 triggers TRPV1, releasing substance P and CGRP, which amplify inflammation — and gut dysbiosis further fuels this loop.

What the researchers found

Nanoplastic exposure (20 nm polystyrene particles) worsened asthma in mice through a multi-step mechanism: the particles activated PLA2 in lung tissue, producing inflammatory metabolites that upregulated TRPV1 channels. This triggered release of neuropeptides substance P and calcitonin gene-related peptide (CGRP), which activated NF-κB signaling and amplified Th2 inflammation (elevated IL-4, IL-5, IL-13). Simultaneously, nanoplastics disrupted gut microbiota, increasing gram-negative bacteria that released LPS, activating the intestinal TLR4/NF-κB pathway and fueling lung inflammation through the gut-lung axis. Reduced short-chain fatty acid production from dysbiosis further enhanced lung PLA2 activity, creating a self-reinforcing PLA2-TRPV1-neuropeptide feedback loop.

Why it matters

This study reveals how environmental nanoplastic pollution could worsen respiratory diseases through neuropeptide-mediated neuroimmune crosstalk. The discovery that substance P and CGRP form part of a positive feedback loop connecting gut microbiota disruption to lung inflammation provides new therapeutic targets and highlights the broader health impacts of microplastic exposure.

The numbers in context

20 nm polystyrene nanoparticles · elevated IL-4, IL-5, IL-13 · reduced IFN-γ · increased 8-OHdG · increased Pseudomonadota, Actinomycetota, Verrucomicrobiota · elevated prostaglandin E2 and leukotriene B4

How the study worked

Researchers used an OVA-sensitized mouse model of asthma exposed to 20 nm polystyrene nanoplastics. They measured airway hyperresponsiveness, performed histopathological analysis of lung tissue (HE, PAS, Masson staining), detected PLA2 and TRPV1 expression by immunohistochemistry, quantified serum immunoglobulins and tissue cytokines, and conducted lung metabolomics and gut microbiota profiling.

Who was studied

OVA-sensitized BALB/c mice exposed to polystyrene nanoplastics

What this study cannot tell us

This is a mouse model study using a specific type and size of nanoplastic (20 nm polystyrene), which may not represent the diverse nanoplastics humans encounter. The OVA sensitization model is a standard but simplified representation of human asthma. Direct translation of the gut microbiota findings from mice to humans requires caution due to differences in microbiome composition.

How to read the evidence

This is a mechanistic animal study using a well-established mouse model of asthma. It provides detailed pathway-level evidence but is preclinical, and the findings need to be validated in human studies before clinical application.

When this study was published

Published in 2026, this is a cutting-edge study addressing the emerging concern of nanoplastic pollution and its impact on respiratory health through neuropeptide signaling.

The bigger picture

This study connects three hot research areas: microplastic pollution, the gut-lung axis, and neuropeptide-mediated inflammation. It provides mechanistic evidence for how environmental pollutants can hijack the body's neuropeptide signaling systems to worsen allergic disease, and it suggests that both neuropeptide-targeted therapies and microbiome restoration could be strategies for addressing pollution-related asthma.

Questions still open

Could blocking substance P or CGRP signaling protect against nanoplastic-induced asthma exacerbation?
Do other types and sizes of nanoplastics produce the same neuropeptide-mediated inflammatory cascade?
Could probiotic or prebiotic interventions that restore short-chain fatty acid production break the gut-lung inflammatory feedback loop?

Common questions

What role do neuropeptides play in this nanoplastic-asthma connection?

The neuropeptides substance P and CGRP act as amplifiers of inflammation. When nanoplastics activate the TRPV1 channel in lung tissue, these peptides are released and activate the NF-κB inflammatory pathway, driving a Th2 immune response that worsens asthma symptoms. They form part of a feedback loop that keeps the inflammation going.

What is the gut-lung axis and how do nanoplastics exploit it?

The gut-lung axis is a communication pathway between the intestinal and respiratory systems. Nanoplastics disrupt gut bacteria, causing harmful bacteria to release inflammatory molecules (LPS) that travel to the lungs and worsen inflammation. The gut disruption also reduces beneficial short-chain fatty acids, further amplifying the lung's inflammatory response through the PLA2-TRPV1-neuropeptide pathway.

Read the original research

Gut-lung axis: a novel mechanism involving microbiota dysbiosis-coordinated PLA2-TRPV1 neuroimmune crosstalk in nanoplastic-induced asthma exacerbation.

Environment international, 207, 110047

View on PubMed ↗Publisher’s paper ↗

Citation

Zeng, Xin; He, Chuhao; Li, Jitong; Feng, Qing; Lu, Zhenjie; Li, Long; Qiao, Yongkang; Han, Wei; Wang, Faming; Chen, Mingqing; Lu, Chan; She, Rong; Wu, Yang; Sun, Yanling; Yang, Xu; Ma, Ping; Lu, Surui. (2026). Gut-lung axis: a novel mechanism involving microbiota dysbiosis-coordinated PLA2-TRPV1 neuroimmune crosstalk in nanoplastic-induced asthma exacerbation.. Environment international, 207, 110047. https://doi.org/10.1016/j.envint.2026.110047